Drug Development

Regulatory Approval Phase 3 Trials FDA Approval Eli Lilly Cancer Treatments Regulatory Affairs Phase 2 Trials Efficacy Studies Combination Therapy Oncology

3 ARTICLES

2w ago

AI Reveals Thousands of Previously Hidden Cortical Lesions on Routine MS MRIs

The University at Buffalo team used a new multimodal enhancement pipeline to expose widespread gray‑matter damage on standard scans, with prospective clinical validation needed.

7 ARTICLES

last mo.

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

7 ARTICLES

2mo ago

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

7 ARTICLES

2mo ago

Oral GLP-1 Weight-Loss Pills Curb Hedonic Eating by Hitting Deep-Brain Circuit in Mice

3 ARTICLES

2mo ago

Avalo Therapeutics Reports Positive Phase 2 HS Results, Prices $375 Million Offering

9 ARTICLES

3mo ago

FDA Approves Filspari to Reduce Proteinuria in FSGS Patients Without Nephrotic Syndrome

3 ARTICLES

4mo ago

Cancer Study Maps Brain Metastasis Switch and Identifies Ibudilast as a Repurposing Candidate

14 ARTICLES

5mo ago

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

19 ARTICLES

5mo ago

Polilaminina Enters Anvisa-Approved Phase 1 as Off-Protocol Use Expands and Scientists Urge Caution

5 ARTICLES

5mo ago

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

9 ARTICLES

5mo ago

Hypoxia Turns Red Blood Cells Into Glucose Sinks, Pointing to New Diabetes Therapies

3 ARTICLES

5mo ago

Low-Dose THC Paired With Celecoxib Improves Cognition and Alzheimer’s Pathology in Mice

3 ARTICLES

8mo ago

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

3 ARTICLES

8mo ago

Immune Cell Stress Switch Implicated in Chemo Neuropathy, With Existing Inhibitors Poised for Tests

6 ARTICLES

8mo ago

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

3 ARTICLES

9mo ago

UC San Diego AI Identifies PRKAB1 Target to Reprogram Colon Cancer Stem Cells

3 ARTICLES

9mo ago

Amivantamab ‘Smart Jab’ Shows 76% Disease Control in Advanced Head and Neck Cancer

3 ARTICLES

9mo ago

Blocking C5aR1 Preserves Memory in Mouse Brain Radiotherapy Without Undermining Tumor Control

4 ARTICLES

10mo ago

NRG Therapeutics Raises £50M to Advance Mitochondrial Neurodegeneration Drug Into the Clinic

3 ARTICLES

11mo ago

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

Drug Development

AI Reveals Thousands of Previously Hidden Cortical Lesions on Routine MS MRIs

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

Oral GLP-1 Weight-Loss Pills Curb Hedonic Eating by Hitting Deep-Brain Circuit in Mice

Avalo Therapeutics Reports Positive Phase 2 HS Results, Prices $375 Million Offering

FDA Approves Filspari to Reduce Proteinuria in FSGS Patients Without Nephrotic Syndrome

Cancer Study Maps Brain Metastasis Switch and Identifies Ibudilast as a Repurposing Candidate

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

Polilaminina Enters Anvisa-Approved Phase 1 as Off-Protocol Use Expands and Scientists Urge Caution

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

Never miss stories about

Drug Development

Hypoxia Turns Red Blood Cells Into Glucose Sinks, Pointing to New Diabetes Therapies

Low-Dose THC Paired With Celecoxib Improves Cognition and Alzheimer’s Pathology in Mice

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Immune Cell Stress Switch Implicated in Chemo Neuropathy, With Existing Inhibitors Poised for Tests

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

UC San Diego AI Identifies PRKAB1 Target to Reprogram Colon Cancer Stem Cells

Amivantamab ‘Smart Jab’ Shows 76% Disease Control in Advanced Head and Neck Cancer

Blocking C5aR1 Preserves Memory in Mouse Brain Radiotherapy Without Undermining Tumor Control

NRG Therapeutics Raises £50M to Advance Mitochondrial Neurodegeneration Drug Into the Clinic

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

Never miss stories about

Drug Development